Literature DB >> 14696511

Helicobacter pylori infection in hemodialysis patients.

Katsuhiko Tsukada1, Tatsuya Miyazaki, Hiroyuki Katoh, Minako Yoshikawa, Norihiro Masuda, Hitoshi Ojima, Kohei Tajima, Yasuyuki Fukai, Masanobu Nakajima, Youichi Kamiyama, Hiroyuki Kuwano, Osamu Tsukada.   

Abstract

BACKGROUND/AIMS: Studies on the relationship between high serum urea nitrogen, creatinine and Helicobacter pylori infection in hemodialysis patients still give conflicting results. In the present study we investigated the prevalence of Helicobacter pylori positivity in patients with hemodialysis [HD(+)] and without hemodialysis [HD(-)] and assessed the relationship between clinical factors, serum urea nitrogen, creatinine levels and Helicobacter pylori prevalence in these patients.
METHODOLOGY: 117 patients with dyspeptic complaints were included in the study. They consisted of 36 HD(+) patients (31%) and 81 HD(-) patients (69%). Endoscopy was performed and gastric antral biopsies were obtained for immunohistochemical analysis for Helicobacter pylori in all patients.
RESULTS: Helicobacter pylori was positive in 53(45%) of 117 patients [Hp(+)]. In univariate analysis Hp(+) patients received hemodialysis therapy significantly less often (P = 0.002) and had lower serum urea nitrogen (P = 0.0008) and creatinine (P = 0.003) levels than Hp(-) patients. There was no significant difference in age, gender, endoscopic findings or comorbid conditions (hypertension or diabetes mellitus) between these groups. Multivariate logistic regression analysis revealed that only the serum urea nitrogen level was significantly associated with Helicobacter pylori prevalence (P = 0.008).
CONCLUSIONS: These results indicate that high serum urea nitrogen seems to correlate with a low prevalence of Helicobacter pylori infection and hemodialysis patients with high serum urea nitrogen may be protected against Helicobacter pylori infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14696511

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

Review 1.  Immunostimulation in the era of the metagenome.

Authors:  Amy D Proal; Paul J Albert; Greg P Blaney; Inge A Lindseth; Chris Benediktsson; Trevor G Marshall
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis.

Authors:  Tomohiko Moriyama; Takayuki Matsumoto; Katsuya Hirakawa; Hirofumi Ikeda; Kazuhiko Tsuruya; Hideki Hirakata; Mitsuo Iida
Journal:  J Gastroenterol       Date:  2010-01-19       Impact factor: 7.527

3.  Helicobacter pylori infection and gastroduodenal lesions in children with chronic kidney disease stage V.

Authors:  Oguz Canan; Figen Ozcay; Ferda Ozbay-Hosnut; Nurcan Cengiz; Esra Baskın
Journal:  Pediatr Nephrol       Date:  2012-07-29       Impact factor: 3.714

4.  Comparison of azithromycin and clarithromycin triple therapy regimens for helicobacter pylori eradication in hemodialysis patients.

Authors:  Mojgan Jalalzadeh; Morteza Nazarian; Jamshid Vafaeimanesh; Fatemeh Mirzamohammadi
Journal:  Nephrourol Mon       Date:  2012-06-20

5.  Association between Helicobacter pylori and end-stage renal disease: A meta-analysis.

Authors:  Karn Wijarnpreecha; Charat Thongprayoon; Pitchaphon Nissaisorakarn; Natasorn Lekuthai; Veeravich Jaruvongvanich; Kiran Nakkala; Ridhmi Rajapakse; Wisit Cheungpasitporn
Journal:  World J Gastroenterol       Date:  2017-02-28       Impact factor: 5.742

6.  Helicobacter pylori Infection in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Suk Pyo Shin; Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.